Amdocs

DOX

Market cap $9.07B

JERSEY CITY, NJ / ACCESS Newswire / December 15, 2025 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, has filed its Annual Report on Form 20-F for the fiscal year ended September 30, 2025 (including its financial statements for such year) with the U.S. Securities and Exchange Commission. The annual report is available through the Company's website (https://investors.amdocs.com/financial-information/sec-filings).

Amdocs (DOX) reported earnings 30 days ago. What's next for the stock?

Amdocs Limited (DOX) Presents at 53rd Annual Nasdaq Investor Conference Transcript

Leveraging Amdocs' amAIz - generative AI Platform and its agents, powered by NVIDIA AI Enterprise, e& UAE is integrating generative AI into its business processes, opening possibilities for new revenue opportunities, business efficiencies, and improved customer experiences DUBAI, UAE AND JERSEY CITY, NJ / ACCESS Newswire / December 9, 2025 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced it has been selected by e& UAE, the flagship telecom arm of global technology group e&, in the United Arab Emirates, to integrate generative AI (GenAI) into its business systems. Using Amdocs' GenAI platform, amAIz , e& UAE can easily integrate GenAI services across its ecosystem.

The Wasatch Global Value Fund - Investor Class gained 6.36% in the third quarter of 2025, outperforming the MSCI All Country World Value Index, which added 6.13%. Leading contributors to the Fund's performance included Chinese e-commerce giant Alibaba Group. Leading detractors from Fund performance for the quarter included Centene Corp.

Investors need to pay close attention to Amdocs stock based on the movements in the options market lately.

Tesla shareholders recently approved Elon Musk's $1 trillion pay package. The compensation plan has the potential to make the world's richest person also the world's first trillionaire.

I continue to rate Amdocs as a 'Hold,' following my evaluation of its performance, outlook, and valuations. DOX's 4QFY25 earnings were in line with consensus, as its above-expectations top line was negated by weaker-than-expected margins. I'm not expecting major surprises relating to FY26 results after analyzing the company's backlog and GenAI-related investment plan.

Evaluate Amdocs' (DOX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Amdocs Limited (NASDAQ:DOX) reported better-than-expected earnings for the fourth quarter on Tuesday.